Exploring beta blocking as a possible mechanism of anticancer action of 2- thiohydantoins

3rd International Conference on Chemo and BioInformatics, Kragujevac, September 25-26. 2025. (pp. 640-643) 

 

AUTOR(I) / AUTHOR(S): Petar B. Stanić, Biljana M. Šmit

 

Download Full Pdf   

DOI:  10.46793/ICCBIKG25.640S

SAŽETAK / ABSTRACT:

This study is a continuation of our previous work in which we examined the anticancer potential of a series of zingerone 2-thiohydantoin derivatives. Using molecular docking, we explored whether beta blocking is a possible mechanism of their anticancer action. Active and inactive derivatives were docked into the structure of the beta-2 adrenergic receptor and their preferred binding sites, binding affinities and interactions were compared and discussed. The results show a discernible difference in which the active and inactive derivatives interact with the receptor and indicate that beta blocking could be a possible mechanism of their anticancer action.

KLJUČNE REČI / KEYWORDS:

2-thiohydantoin, beta-2 adrenergic receptor, molecular docking

PROJEKAT / ACKNOWLEDGEMENT:

This research is funded by the Ministry of Education and Ministry of Science, Technological Development and Innovation, Republic of Serbia, Grant No. 451-03- 136/2025-03/200378.

LITERATURA / REFERENCES:

  • P.P. Gawas, B. Ramakrishna, N. Veeraiah., V. Nutalapati, Multifunctional hydantoins: recent advances in optoelectronics and medicinal drugs from Academia to the chemical industry, Journal of Materials Chemistry C, 9 (2021) 16341-16377.
  • A. K. Gupta, G.S. Thakur, S.K. Jain., Recent Development in Hydantoins, Thiohydantoins, and Selenohydantoins as Anticancer Agents: Structure-activity Relationship and Design Strategies, Mini- Reviews in Medicinal Chemistry, 25 (2025) 693-726.
  • B. Mravec, L. Horvathova, L. Hunakova., Neurobiology of Cancer: The Role of β-Adrenergic Receptor Signaling in Various Tumor Environments, International Journal of Molecular Sciences, 21 (2020) 7958.
  • K. Virijević, P. Stanić, J. Muškinja, J. Katanić Stanković, N. Srećković, M. Živanović, B. Šmit., Synthesis and biological activity of novel zingerone–thiohydantoin hybrids, Journal of the Serbian Chemical Society 87 (2022) 1349–1358.
  • M.J. Frisch, G.W. Trucks, H.B. Schlegel, et al., Gaussian 09, Revision C.01. Wallingford CT: Gaussian, Inc.; 2009.
  • O. Trott, A.J. Olson., AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, Journal of Computational Chemistry, 31 (2010) 455–461.
  • D. Wacker, G. Fenalti, M.A. Brown, V. Katritch, R. Abagyan, V. Cherezov, R.C. Stevens., Conserved Binding Mode of Human β2 Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography, Journal of the American Chemical Society, 132 (2010) 11443– 11445.
  • Dassault Systemes, BIOVIA. Discovery Studio Modelling Environment, Release 2017, Dassault Systemes. San Diego, CA, USA; 2016.